Please complete the CAPTCHA to continue
@cairnbio.com
✓
3 phones found area 415
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Mary Ludlam (Cole) is listed as Entrepreneur & Drug Discovery Innovator at Cairn Biosciences, based in San Francisco Bay Area, United States. AeroLeads shows a work email signal at cairnbio.com, phone signal with area code 415, and a matched LinkedIn profile for Mary Ludlam (Cole).
Mary Ludlam (Cole) previously worked as Founder & CEO at Cairn Biosciences and Scientist & Group Leader, Discovery Oncology at Genentech. Mary Ludlam (Cole) holds Ph.D., Ultrafast Laser Physics & Fluorescence Spectroscopy from Imperial College London.
This section adds company-level context without repeating Mary Ludlam (Cole)'s masked contact details.
AeroLeads found 1 current-domain work email signal for Mary Ludlam (Cole). Compare company email patterns before reaching out.
• Pioneer and expert in the development of novel technologies that have delivered critical insights to the development of blockbuster oncology drugs, notably polatuzumab and venetoclax. • Multifaceted and driven scientific leader with broad drug discovery expertise including cell biology, high-throughput technologies, biophysics and preclinical in vivo research.• 20+ years of biopharma industry experience including critical contributions to large and small molecule oncology therapeutic programs spanning target validation and lead discovery through IND and clinical trials.• Experienced, perceptive and entrepreneurial leader with unique experience building and developing exceptional multidisciplinary teams to chase bold drug discovery goals
Listed skills include Drug Discovery, Assay Development, Cell Biology, Microscopy, and 32 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
San Francisco, California, Us
Cairn Biosciences is an early stage platform-enabled therapeutics discovery company. By experimentally simulating living biology, our COMPASS platform unlocks exclusive pathways to intervene in the progression of serious diseases.
South San Francisco, California, Us
• Led delivery of key cell biology data and technical breakthroughs to diverse oncology research and small molecule drug discovery programs.• Pioneered the adoption of innovative live cell assays into several lead discovery and lead optimization campaigns for challenging protein-protein interactions and 'undruggable' targets.• Developed unique assays that enabled critical insights into the cellular potency and target specificity of a Bcl-2 selective inhibitor (ABT-199) , now FDA-approved venetoclax.• Spearheaded the development of novel cell line engineering, assay automation, high-content microscopy and image analysis approaches to support small molecule discovery programs resulting in 8 publications.
South San Francisco, California, Us
• Pioneered the use of preclinical optical imaging at Genentech. • Developed and implemented optical imaging technologies that delivered critical insights to multiple late-stage preclinical small molecule and antibody oncology therapeutic programs, notably Policy and Avastin.• Authored 10 publications, 3 patents and contributed data to several IND submissions and an FDA ODAC committee presentation.• Showcased team’s data at Genentech Scientific Review Board and Executive Committee meetings.
Hamburg, De
• Introduced high-throughput FLIM to Evotec’s portfolio of screening technologies.• Collaborated with engineering and informatics teams to incorporate FLIM into Evotec’s OPERA high-content screening platform (acquired by Perkin Elmer). • Broadened experience to include single molecule fluorescence biophysical measurement techniques (FP, FRET, FCS etc.) and their application to high throughput screening assays.
Quick answers generated from the profile data available on this page.
Mary Ludlam (Cole) works for Cairn Biosciences.
Mary Ludlam (Cole) is listed as Entrepreneur & Drug Discovery Innovator at Cairn Biosciences.
AeroLeads has found 1 work email signal at @cairnbio.com for Mary Ludlam (Cole) at Cairn Biosciences.
AeroLeads has found 3 phone signal(s) with area code 415 for Mary Ludlam (Cole) at Cairn Biosciences.
Mary Ludlam (Cole) is based in San Francisco Bay Area, United States while working with Cairn Biosciences.
Mary Ludlam (Cole) has worked for Cairn Biosciences, Genentech, and Evotec.
You can use AeroLeads to view verified contact signals for Mary Ludlam (Cole) at Cairn Biosciences, including work email, phone, and LinkedIn data when available.
Mary Ludlam (Cole) holds Ph.D., Ultrafast Laser Physics & Fluorescence Spectroscopy from Imperial College London.
Mary Ludlam (Cole) is listed with skills including Drug Discovery, Assay Development, Cell Biology, Microscopy, Cell, Molecular Biology, High Throughput Screening, and Cell Culture.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts